The Royal Melbourne Hospital Foundation

Among their complaints were inconsistent structure, not enough information, and heavy use of jargon and abbreviations that were specialty-specific.

According to an audit conducted at Royal Melbourne Hospital, one in five words in a discharge summary is an abbreviation or an initialism, 7% of which could be ambiguous.

Does MS stand for multiple sclerosis or mitral stenosis? Is PE a pulmonary embolism or a pleural effusion? Was that meant to be QD, QOD or QID, potentially an eightfold difference in dosing? Another study published in the MJA in 2015 found that common initialisms such as TTE, EST, and NKDA were misinterpreted by around a third of the 155 GPs surveyed.

If you too are scratching your head, they'd be transthoracic echocardiogram, exercise stress testing, and no known drug allergies.

I'll begin today with a deep dive into the journey that we went down to make mutual governance pathway something that was possible at our three hospitals.

And then we'll move on to a brief outline of how AI is governed at Melbourne Health.

So just a quick slide with a little reminder about what research governance is, or rather a reminder that once a research project has human research ethics committee approval, the next step is research governance review by the individual institutions or sites that are actually going to be doing the research.

Research governance oversight is about how the institution ensures that the research it's conducting isn't just ethically approved but also appropriate and compliant with its own requirements.

That would of course mean less work and less burden for everybody.

In reality, that's been prohibitively hard to achieve.

And that's why I'm proud that Melbourne Health, Peter Mac and Royal Women's have pulled off what I believe is a national first in getting this up and running for our three hospitals.

Now, it's important to understand that these three hospitals, Peter Mac, Royal Melbourne, Royal Women's, are more or less co-located.

It's the only one I'm in trouble with, my mum.

So Steve T is an infectious diseases physician at the Royal Melbourne Hospital in Melbourne, Australia, and he's a professor of infectious diseases at the University of Melbourne.

And Steve also co-leads the ASCOT trial, which we might hear a little bit about later, but is also about COVID and flu.

Hi everyone, great to be back.

That was during my senior primary school year.

So I've had exposure to the wonder, if you like, um, isolated and rural parts of Australia, and that planted something in me which ultimately led to me making a decision to leave Melbourne when I'd finished my medical student years at the Royal Melbourne Hospital and come to Ballarat, where I undertook my immediate postgraduate training years as we all do as young doctors.

So that was the start of it, and realizing that there was something special about the small country towns that are chronically underserved in terms of medical and nursing resources.

I've had a lot to do with towns all the way up to the South Australian border in education for the GPs and the nursing staff and the ambulance officers.

Um, so yeah, my name is Karen Dwyer.

I'm from the Royal Melbourne Hospital, and I wanted to talk today about the cardiac kidney metabolic syndrome, which is a relatively new, uh, new concept.

Um, just to outline, um, m- my sort of research portfolio and where I'm getting my funding from.

So I've got some active projects at the moment.